Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities

Summary: Apoptotic cell death removes unwanted cells and is regulated by interactions between pro-survival and pro-apoptotic members of the BCL-2 protein family. The regulation of apoptosis is thought to be crucial for normal embryonic development. Accordingly, complete loss of pro-survival MCL-1 or...

Full description

Bibliographic Details
Main Authors: Stephanie Grabow, Andrew J. Kueh, Francine Ke, Hannah K. Vanyai, Bilal N. Sheikh, Michael A. Dengler, William Chiang, Samantha Eccles, Ian M. Smyth, Lynelle K. Jones, Frederic J. de Sauvage, Mark Scott, Lachlan Whitehead, Anne K. Voss, Andreas Strasser
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124718313342
_version_ 1819010304143523840
author Stephanie Grabow
Andrew J. Kueh
Francine Ke
Hannah K. Vanyai
Bilal N. Sheikh
Michael A. Dengler
William Chiang
Samantha Eccles
Ian M. Smyth
Lynelle K. Jones
Frederic J. de Sauvage
Mark Scott
Lachlan Whitehead
Anne K. Voss
Andreas Strasser
author_facet Stephanie Grabow
Andrew J. Kueh
Francine Ke
Hannah K. Vanyai
Bilal N. Sheikh
Michael A. Dengler
William Chiang
Samantha Eccles
Ian M. Smyth
Lynelle K. Jones
Frederic J. de Sauvage
Mark Scott
Lachlan Whitehead
Anne K. Voss
Andreas Strasser
author_sort Stephanie Grabow
collection DOAJ
description Summary: Apoptotic cell death removes unwanted cells and is regulated by interactions between pro-survival and pro-apoptotic members of the BCL-2 protein family. The regulation of apoptosis is thought to be crucial for normal embryonic development. Accordingly, complete loss of pro-survival MCL-1 or BCL-XL (BCL2L1) causes embryonic lethality. However, it is not known whether minor reductions in pro-survival proteins could cause developmental abnormalities. We explored the rate-limiting roles of MCL-1 and BCL-XL in development and show that combined loss of single alleles of Mcl-1 and Bcl-x causes neonatal lethality. Mcl-1+/–;Bcl-x+/– mice display craniofacial anomalies, but additional loss of a single allele of pro-apoptotic Bim (Bcl2l11) restores normal development. These findings demonstrate that the control of cell survival during embryogenesis is finely balanced and suggest that some human craniofacial defects, for which causes are currently unknown, may be due to subtle imbalances between pro-survival and pro-apoptotic BCL-2 family members. : Grabow et al. find that combined loss of single alleles of pro-survival Mcl-1 and Bcl-x causes craniofacial defects, including holoprosencephaly, a severe birth defect. Normal development is restored by concomitant loss of a single allele of pro-apoptotic Bim, revealing that cell survival and cell death during embryogenesis are finely balanced. Keywords: MCL-1, MCL1, BCL-XL, BCL2L1, BIM, BCL2L11, apoptosis, embryonic development, holoprosencephaly, cyclopia
first_indexed 2024-12-21T01:10:08Z
format Article
id doaj.art-b958c8def9dc4e4eb7387f18421e59a4
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-21T01:10:08Z
publishDate 2018-09-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-b958c8def9dc4e4eb7387f18421e59a42022-12-21T19:20:57ZengElsevierCell Reports2211-12472018-09-01241232853295.e4Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial AbnormalitiesStephanie Grabow0Andrew J. Kueh1Francine Ke2Hannah K. Vanyai3Bilal N. Sheikh4Michael A. Dengler5William Chiang6Samantha Eccles7Ian M. Smyth8Lynelle K. Jones9Frederic J. de Sauvage10Mark Scott11Lachlan Whitehead12Anne K. Voss13Andreas Strasser14The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, Australia; Corresponding authorThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, AustraliaDevelopment and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia; Department of Anatomy and Developmental Biology and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3800, AustraliaDevelopment and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia; Department of Anatomy and Developmental Biology and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3800, AustraliaDepartment of Molecular Oncology, Genentech, South San Francisco, CA 94080, USAThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, AustraliaThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, Australia; Corresponding authorThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, Australia; Corresponding authorSummary: Apoptotic cell death removes unwanted cells and is regulated by interactions between pro-survival and pro-apoptotic members of the BCL-2 protein family. The regulation of apoptosis is thought to be crucial for normal embryonic development. Accordingly, complete loss of pro-survival MCL-1 or BCL-XL (BCL2L1) causes embryonic lethality. However, it is not known whether minor reductions in pro-survival proteins could cause developmental abnormalities. We explored the rate-limiting roles of MCL-1 and BCL-XL in development and show that combined loss of single alleles of Mcl-1 and Bcl-x causes neonatal lethality. Mcl-1+/–;Bcl-x+/– mice display craniofacial anomalies, but additional loss of a single allele of pro-apoptotic Bim (Bcl2l11) restores normal development. These findings demonstrate that the control of cell survival during embryogenesis is finely balanced and suggest that some human craniofacial defects, for which causes are currently unknown, may be due to subtle imbalances between pro-survival and pro-apoptotic BCL-2 family members. : Grabow et al. find that combined loss of single alleles of pro-survival Mcl-1 and Bcl-x causes craniofacial defects, including holoprosencephaly, a severe birth defect. Normal development is restored by concomitant loss of a single allele of pro-apoptotic Bim, revealing that cell survival and cell death during embryogenesis are finely balanced. Keywords: MCL-1, MCL1, BCL-XL, BCL2L1, BIM, BCL2L11, apoptosis, embryonic development, holoprosencephaly, cyclopiahttp://www.sciencedirect.com/science/article/pii/S2211124718313342
spellingShingle Stephanie Grabow
Andrew J. Kueh
Francine Ke
Hannah K. Vanyai
Bilal N. Sheikh
Michael A. Dengler
William Chiang
Samantha Eccles
Ian M. Smyth
Lynelle K. Jones
Frederic J. de Sauvage
Mark Scott
Lachlan Whitehead
Anne K. Voss
Andreas Strasser
Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities
Cell Reports
title Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities
title_full Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities
title_fullStr Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities
title_full_unstemmed Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities
title_short Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities
title_sort subtle changes in the levels of bcl 2 proteins cause severe craniofacial abnormalities
url http://www.sciencedirect.com/science/article/pii/S2211124718313342
work_keys_str_mv AT stephaniegrabow subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT andrewjkueh subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT francineke subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT hannahkvanyai subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT bilalnsheikh subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT michaeladengler subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT williamchiang subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT samanthaeccles subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT ianmsmyth subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT lynellekjones subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT fredericjdesauvage subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT markscott subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT lachlanwhitehead subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT annekvoss subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities
AT andreasstrasser subtlechangesinthelevelsofbcl2proteinscauseseverecraniofacialabnormalities